King and Pain to resubmit abuse-resistant analgesic Remoxy
This article was originally published in Scrip
Executive Summary
King Therapeutics and Pain Therapeutics plan to resubmit their abuse-resistant analgesic Remoxy (oxycodone) in the middle of 2010, after generating six-month stability data. King said that no new clinical trials are required.